| Abonnieren, um auf vollständige Daten zuzugreifen | ||||||
|---|---|---|---|---|---|---|
| Unternehmen | Geschäftsfeld | Marktkapitalisierung ($) | # Insidern mit Nettokäufen | Nettowert gekauft ($) | % des Streubesitzes gekauft | % der von Insidern gehaltenen Aktien |
|
|
Healthcare Services | Nano (14.3mn) | 1–5 | < $100K | 0–15% | 0–15% |
| Healthcare Services | Nano (14.2mn) | 1–5 | < $100K | 0–15% | 0–15% | |
|
|
Pharmaceuticals & Medical Research | Nano (14.2mn) | 0 | Keine Aktivität | — | 0–15% |
|
|
Healthcare Services | Nano (14.1mn) | 0 | Keine Aktivität | — | 15–50% |
|
|
Healthcare Services | Nano (14.1mn) | 0 | Keine Aktivität | — | 15–50% |
| Healthcare Services | Nano (14.1mn) | 0 | Keine Aktivität | — | 50%+ | |
|
|
Healthcare Services | Nano (14.1mn) | 1–5 | < $100K | 0–15% | 50%+ |
|
|
Healthcare Services | Nano (13.9mn) | 0 | Keine Aktivität | — | — |
| Healthcare Services | Nano (13.9mn) | 0 | Keine Aktivität | — | 50%+ | |
|
|
Pharmaceuticals & Medical Research | Nano (13.8mn) | 0 | Keine Aktivität | — | 15–50% |
|
|
Healthcare Services | Nano (13.8mn) | 0 | Keine Aktivität | — | 15–50% |
|
|
Healthcare Services | Nano (13.7mn) | 0 | Keine Aktivität | — | 50%+ |
| Pharmaceuticals & Medical Research | Nano (13.7mn) | 0 | Keine Aktivität | — | 15–50% | |
|
|
Healthcare Services | Nano (13.6mn) | 0 | Keine Aktivität | — | 0–15% |
|
|
Healthcare Services | Nano (13.6mn) | 0 | Keine Aktivität | — | 15–50% |
|
|
Pharmaceuticals & Medical Research | Nano (13.5mn) | 1–5 | $100K–$1M | 0–15% | — |
|
|
Healthcare Services | Nano (13.3mn) | 0 | Keine Aktivität | — | 50%+ |
|
|
Healthcare Services | Nano (13.3mn) | 0 | Keine Aktivität | — | 15–50% |
|
|
Pharmaceuticals & Medical Research | Nano (13.3mn) | 0 | Keine Aktivität | — | 15–50% |
|
|
Healthcare Services | Nano (13.3mn) | 0 | Keine Aktivität | — | 50%+ |
|
|
Pharmaceuticals & Medical Research | Nano (13.2mn) | 0 | Keine Aktivität | — | 15–50% |
|
|
Pharmaceuticals & Medical Research | Nano (13.2mn) | 0 | Keine Aktivität | — | 15–50% |
|
|
Pharmaceuticals & Medical Research | Nano (13.1mn) | 1–5 | $100K–$1M | 0–15% | 15–50% |
|
|
Pharmaceuticals & Medical Research | Nano (13.1mn) | 0 | Keine Aktivität | — | 15–50% |
|
|
Pharmaceuticals & Medical Research | Nano (13.0mn) | 0 | Keine Aktivität | — | 50%+ |
|
|
Healthcare Services | Nano (13.0mn) | 0 | Keine Aktivität | — | 15–50% |
|
|
Pharmaceuticals & Medical Research | Nano (12.9mn) | 0 | Keine Aktivität | — | — |
|
|
Healthcare Services | Nano (12.7mn) | 0 | Keine Aktivität | — | 15–50% |
|
|
Healthcare Services | Nano (12.6mn) | 0 | Keine Aktivität | — | 0–15% |
|
|
Pharmaceuticals & Medical Research | Nano (12.5mn) | -1–5 | -< $100K | -0–15% | 15–50% |
|
|
Healthcare Services | Nano (12.4mn) | 0 | Keine Aktivität | — | 15–50% |
|
|
Pharmaceuticals & Medical Research | Nano (12.4mn) | 0 | Keine Aktivität | — | 0–15% |
|
|
Pharmaceuticals & Medical Research | Nano (12.3mn) | 6–10 | $100K–$1M | 0–15% | 15–50% |
|
|
Pharmaceuticals & Medical Research | Nano (12.3mn) | 0 | Keine Aktivität | — | 0–15% |
|
|
Healthcare Services | Nano (12.2mn) | 0 | Keine Aktivität | — | 0–15% |
| Pharmaceuticals & Medical Research | Nano (12.2mn) | 0 | Keine Aktivität | — | 0–15% | |
|
|
Pharmaceuticals & Medical Research | Nano (12.2mn) | 1–5 | < $100K | 0–15% | 0–15% |
|
|
Pharmaceuticals & Medical Research | Nano (12.1mn) | 0 | Keine Aktivität | — | 0–15% |
|
|
Pharmaceuticals & Medical Research | Nano (12.1mn) | 0 | Keine Aktivität | — | 0–15% |
|
|
Healthcare Services | Nano (12.0mn) | 0 | Keine Aktivität | — | 50%+ |
|
|
Pharmaceuticals & Medical Research | Nano (12.0mn) | 0 | Keine Aktivität | — | 15–50% |
|
|
Pharmaceuticals & Medical Research | Nano (12.0mn) | 0 | Keine Aktivität | — | 15–50% |
|
|
Pharmaceuticals & Medical Research | Nano (12.0mn) | 1–5 | < $100K | 0–15% | 15–50% |
|
|
Healthcare Services | Nano (11.8mn) | 0 | Keine Aktivität | — | 0–15% |
|
|
Pharmaceuticals & Medical Research | Nano (11.8mn) | 0 | Keine Aktivität | — | 0–15% |
|
|
Pharmaceuticals & Medical Research | Nano (11.7mn) | 0 | Keine Aktivität | — | 15–50% |
|
|
Healthcare Services | Nano (11.7mn) | 0 | Keine Aktivität | — | 15–50% |
|
|
Pharmaceuticals & Medical Research | Nano (11.6mn) | 0 | Keine Aktivität | — | 0–15% |
|
|
Pharmaceuticals & Medical Research | Nano (11.6mn) | 0 | Keine Aktivität | — | 15–50% |
|
|
Pharmaceuticals & Medical Research | Nano (11.4mn) | 0 | Keine Aktivität | — | 15–50% |
|
|
Pharmaceuticals & Medical Research | Nano (11.3mn) | 0 | Keine Aktivität | — | 0–15% |
|
|
Pharmaceuticals & Medical Research | Nano (11.3mn) | 0 | < $100K | 0–15% | 15–50% |
|
|
Pharmaceuticals & Medical Research | Nano (11.3mn) | 0 | Keine Aktivität | — | 50%+ |
| Pharmaceuticals & Medical Research | Nano (11.3mn) | 0 | Keine Aktivität | — | 50%+ | |
|
|
Pharmaceuticals & Medical Research | Nano (11.3mn) | 1–5 | < $100K | 0–15% | 0–15% |
|
|
Healthcare Services | Nano (11.1mn) | 0 | Keine Aktivität | — | 50%+ |
|
|
Pharmaceuticals & Medical Research | Nano (11.1mn) | 0 | Keine Aktivität | — | 0–15% |
|
|
Pharmaceuticals & Medical Research | Nano (11.0mn) | 0 | Keine Aktivität | — | 15–50% |
|
|
Pharmaceuticals & Medical Research | Nano (11.0mn) | 0 | Keine Aktivität | — | 0–15% |
| Pharmaceuticals & Medical Research | Nano (11.0mn) | 0 | Keine Aktivität | — | 15–50% | |
| Healthcare Services | Nano (11.0mn) | 0 | Keine Aktivität | — | 15–50% | |
|
|
Healthcare Services | Nano (11.0mn) | 0 | Keine Aktivität | — | 15–50% |
|
|
Pharmaceuticals & Medical Research | Nano (10.9mn) | 0 | Keine Aktivität | — | 50%+ |
|
|
Pharmaceuticals & Medical Research | Nano (10.8mn) | 0 | Keine Aktivität | — | 15–50% |
|
|
Pharmaceuticals & Medical Research | Nano (10.8mn) | 0 | Keine Aktivität | — | 15–50% |
|
|
Healthcare Services | Nano (10.7mn) | 0 | Keine Aktivität | — | 15–50% |
|
|
Healthcare Services | Nano (10.7mn) | 0 | Keine Aktivität | — | 15–50% |
|
|
Healthcare Services | Nano (10.6mn) | 0 | Keine Aktivität | — | 0–15% |
|
|
Healthcare Services | Nano (10.6mn) | 0 | Keine Aktivität | — | 0–15% |
|
|
Healthcare Services | Nano (10.6mn) | 0 | Keine Aktivität | — | 15–50% |
| Pharmaceuticals & Medical Research | Nano (10.5mn) | 0 | Keine Aktivität | — | 15–50% | |
|
|
Pharmaceuticals & Medical Research | Nano (10.4mn) | 0 | Keine Aktivität | — | 0–15% |
|
|
Healthcare Services | Nano (10.4mn) | 0 | Keine Aktivität | — | 50%+ |
|
|
Pharmaceuticals & Medical Research | Nano (10.4mn) | 0 | Keine Aktivität | — | 15–50% |
|
|
Pharmaceuticals & Medical Research | Nano (10.4mn) | 0 | Keine Aktivität | — | 0–15% |
|
|
Pharmaceuticals & Medical Research | Nano (10.3mn) | 0 | Keine Aktivität | — | 15–50% |
|
|
Pharmaceuticals & Medical Research | Nano (10.3mn) | 0 | Keine Aktivität | — | 15–50% |
|
|
Pharmaceuticals & Medical Research | Nano (10.2mn) | 0 | Keine Aktivität | — | 0–15% |
|
|
Pharmaceuticals & Medical Research | Nano (10.1mn) | 0 | Keine Aktivität | — | 15–50% |
|
|
Healthcare Services | Nano (9.9mn) | 0 | Keine Aktivität | — | 15–50% |
|
|
Pharmaceuticals & Medical Research | Nano (9.9mn) | 0 | Keine Aktivität | — | 0–15% |
|
|
Healthcare Services | Nano (9.7mn) | 1–5 | $100K–$1M | 0–15% | 15–50% |
|
|
Pharmaceuticals & Medical Research | Nano (9.7mn) | 0 | Keine Aktivität | — | 0–15% |
|
|
Healthcare Services | Nano (9.7mn) | 0 | Keine Aktivität | — | 15–50% |
|
|
Pharmaceuticals & Medical Research | Nano (9.6mn) | 1–5 | < $100K | 0–15% | 50%+ |
|
|
Pharmaceuticals & Medical Research | Nano (9.6mn) | 1–5 | $100K–$1M | 0–15% | 15–50% |
|
|
Healthcare Services | Nano (9.6mn) | 0 | Keine Aktivität | — | 0–15% |
|
|
Pharmaceuticals & Medical Research | Nano (9.6mn) | -1–5 | -< $100K | -0–15% | 0–15% |
|
|
Pharmaceuticals & Medical Research | Nano (9.5mn) | 0 | Keine Aktivität | — | 15–50% |
|
|
Pharmaceuticals & Medical Research | Nano (9.5mn) | 0 | Keine Aktivität | — | 0–15% |
|
|
Pharmaceuticals & Medical Research | Nano (9.5mn) | 1–5 | < $100K | 0–15% | 15–50% |
|
|
Pharmaceuticals & Medical Research | Nano (9.5mn) | 0 | Keine Aktivität | — | 50%+ |
|
|
Pharmaceuticals & Medical Research | Nano (9.5mn) | -1–5 | -< $100K | -50%+ | 0–15% |
|
|
Healthcare Services | Nano (9.4mn) | 0 | Keine Aktivität | — | 15–50% |
|
|
Healthcare Services | Nano (9.4mn) | 0 | Keine Aktivität | — | 15–50% |
|
|
Healthcare Services | Nano (9.4mn) | 0 | Keine Aktivität | — | 0–15% |
|
|
Pharmaceuticals & Medical Research | Nano (9.2mn) | 0 | Keine Aktivität | — | 50%+ |
|
|
Pharmaceuticals & Medical Research | Nano (9.2mn) | 0 | Keine Aktivität | — | 0–15% |
|
|
Healthcare Services | Nano (9.2mn) | 0 | Keine Aktivität | — | 50%+ |
|
|
Pharmaceuticals & Medical Research | Nano (9.2mn) | 0 | Keine Aktivität | — | 0–15% |